Gamgee YC Başvurusu

Summer 2026Active

San Francisco

Gamgee, Healthcare şirketi olarak Summer 2026 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Summer 2026
Sektör: HealthcareDrug Discovery and Delivery
Konum: San Francisco
Ekip büyüklüğü: 2
Durum: Active
Lansmanı Yapıldı: 2026

Kurucular

Paul ConynghamFounder/CEO

Gamgee ne yapar

Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next

Gamgee'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

Gamgee, Summer 2026 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Gamgee

Describe what your company does in 50 characters or less.

Personalised mRNA cancer vaccines for dogs.

What is your company going to make? Please describe your product and what it does or will do.

We're building an end-to-end platform for personalised mRNA cancer vaccines for dogs. We start by sequencing a dog's tumour and normal tissue, then use AI to identify and rank tumour-specific mutations. Our platform designs a custom mRNA vaccine targeting these mutations, coordinates production, and works with vets to oversee treatment and monitor outcomes.

Where do you live now, and where would the company be based after YC?

San Francisco, CA, USA; Remote. The company would remain based there after YC.

Explain your decision regarding location.

San Francisco connects us to both biotech resources and the YC ecosystem. We operate remotely to collaborate with labs, vets, and trial sites in Australia and globally.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, Gamgee şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Gamgee'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Gamgee gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.